These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 33838559

  • 1. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS, Almalki AJ, Moustafa AH, Allam RM, Abuo-Rahma GEA, El Subbagh HI, Mohamed MFA.
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
    Hofny HA, Mohamed MFA, Gomaa HAM, Abdel-Aziz SA, Youssif BGM, El-Koussi NA, Aboraia AS.
    Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
    [Abstract] [Full Text] [Related]

  • 3. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS, Askar AA, Naglah AM, Almehizia AA, Ragab A.
    Molecules; 2020 Jun 02; 25(11):. PubMed ID: 32498469
    [Abstract] [Full Text] [Related]

  • 4. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M, Arumugam S.
    Bioorg Med Chem; 2017 Feb 15; 25(4):1448-1455. PubMed ID: 28094220
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
    Liu JJ, Sun J, Fang YB, Yang YA, Jiao RH, Zhu HL.
    Org Biomol Chem; 2014 Feb 14; 12(6):998-1008. PubMed ID: 24382549
    [Abstract] [Full Text] [Related]

  • 6. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
    Liu H, Chu ZW, Xia DG, Cao HQ, Lv XH.
    Bioorg Chem; 2020 Jun 14; 99():103807. PubMed ID: 32272364
    [Abstract] [Full Text] [Related]

  • 7. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
    Omar MA, Masaret GS, Abbas EMH, Abdel-Aziz MM, Harras MF, Farghaly TA.
    Bioorg Chem; 2020 Nov 14; 104():104316. PubMed ID: 33022549
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH.
    Eur J Med Chem; 2022 Jan 15; 228():114021. PubMed ID: 34871841
    [Abstract] [Full Text] [Related]

  • 9. Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains.
    Zidar N, Onali A, Peršolja P, Benedetto Tiz D, Dernovšek J, Skok Ž, Durcik M, Cotman AE, Hrast Rambaher M, Cruz CD, Tammela P, Senerovic L, Jovanovic M, Szili PÉ, Czikkely MS, Pál C, Zega A, Peterlin Mašič L, Ilaš J, Tomašič T, Kikelj D.
    Eur J Med Chem; 2024 Nov 15; 278():116823. PubMed ID: 39236496
    [Abstract] [Full Text] [Related]

  • 10. New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.
    Durcik M, Lovison D, Skok Ž, Durante Cruz C, Tammela P, Tomašič T, Benedetto Tiz D, Draskovits G, Nyerges Á, Pál C, Ilaš J, Peterlin Mašič L, Kikelj D, Zidar N.
    Eur J Med Chem; 2018 Jun 25; 154():117-132. PubMed ID: 29778894
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
    Salem MA, Ragab A, El-Khalafawy A, Makhlouf AH, Askar AA, Ammar YA.
    Bioorg Chem; 2020 Mar 25; 96():103619. PubMed ID: 32036161
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
    El-Shershaby MH, El-Gamal KM, Bayoumi AH, El-Adl K, Ahmed HEA, Abulkhair HS.
    Arch Pharm (Weinheim); 2021 Feb 25; 354(2):e2000277. PubMed ID: 33078877
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors.
    Mohammed HHH, Ali DME, Badr M, Habib AGK, Mahmoud AM, Farhan SM, Gany SSHAE, Mohamad SA, Hayallah AM, Abbas SH, Abuo-Rahma GEA.
    Mol Divers; 2023 Aug 25; 27(4):1751-1765. PubMed ID: 36152132
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors.
    Mohamed NG, Sheha MM, Hassan HY, Abdel-Hafez LJM, Omar FA.
    Bioorg Chem; 2018 Dec 25; 81():599-611. PubMed ID: 30248511
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M, Tammela P, Barančoková M, Tomašič T, Ilaš J, Kikelj D, Zidar N.
    ChemMedChem; 2018 Jan 22; 13(2):186-198. PubMed ID: 29206345
    [Abstract] [Full Text] [Related]

  • 16. Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies.
    Ghannam IAY, Abd El-Meguid EA, Ali IH, Sheir DH, El Kerdawy AM.
    Bioorg Chem; 2019 Dec 22; 93():103373. PubMed ID: 31698294
    [Abstract] [Full Text] [Related]

  • 17. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH, Abdallah SO, Mohsen MMA.
    Bioorg Chem; 2020 Apr 22; 97():103672. PubMed ID: 32145481
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, Docking Studies, and In Vitro Evaluation of Some Novel Thienopyridines and Fused Thienopyridine-Quinolines as Antibacterial Agents and DNA Gyrase Inhibitors.
    Mohi El-Deen EM, Abd El-Meguid EA, Hasabelnaby S, Karam EA, Nossier ES.
    Molecules; 2019 Oct 10; 24(20):. PubMed ID: 31658631
    [Abstract] [Full Text] [Related]

  • 19. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.
    Saleh MA, Elmaaty AA, El Saeed HS, Saleh MM, Salah M, Ezz Eldin RR.
    Bioorg Chem; 2022 Dec 10; 129():106186. PubMed ID: 36215786
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor.
    Abdullah MI, Mahmood A, Madni M, Masood S, Kashif M.
    Bioorg Chem; 2014 Jun 10; 54():31-7. PubMed ID: 24747187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.